Business combinations (Details Narrative) - USD ($) $ in Thousands |
1 Months Ended | 12 Months Ended | |
---|---|---|---|
Nov. 30, 2023 |
Dec. 31, 2024 |
Mar. 20, 2024 |
|
Business Acquisition [Line Items] | |||
Stock issued during period Value acquisitions | $ 400 | ||
Aimia Pet Healthco Inc [Member] | |||
Business Acquisition [Line Items] | |||
Business combination for purchase price | $ 400 | ||
Goodwill amortized over a period | 15 years | ||
Business combination acquisition related costs | $ 100 | ||
Stock issued during period shares acquisitions | 6,818 | ||
Stock issued during period Value acquisitions | $ 100 |
X | ||||||||||
- Definition Goodwill amortized over a period. No definition available.
|
X | ||||||||||
- Definition Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value of stock issued pursuant to acquisitions during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|